Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1890 1
1893 1
1895 1
1926 1
1938 1
1958 4
1961 1
1963 1
1965 6
1966 5
1967 5
1968 5
1969 5
1970 10
1971 8
1972 11
1973 4
1974 9
1975 15
1976 15
1977 20
1978 11
1979 17
1980 19
1981 21
1982 16
1983 11
1984 22
1985 21
1986 11
1987 25
1988 15
1989 14
1990 19
1991 17
1992 14
1993 8
1994 12
1995 16
1996 20
1997 18
1998 21
1999 24
2000 25
2001 22
2002 20
2003 24
2004 27
2005 28
2006 30
2007 55
2008 39
2009 31
2010 41
2011 43
2012 36
2013 41
2014 40
2015 53
2016 52
2017 59
2018 71
2019 52
2020 69
2021 78
2022 66
2023 6
Text availability
Article attribute
Article type
Publication date

Search Results

1,402 results
Results by year
Filters applied: . Clear all
Page 1
An oral SARS-CoV-2 Mpro inhibitor clinical candidate for the treatment of COVID-19.
Owen DR, Allerton CMN, Anderson AS, Aschenbrenner L, Avery M, Berritt S, Boras B, Cardin RD, Carlo A, Coffman KJ, Dantonio A, Di L, Eng H, Ferre R, Gajiwala KS, Gibson SA, Greasley SE, Hurst BL, Kadar EP, Kalgutkar AS, Lee JC, Lee J, Liu W, Mason SW, Noell S, Novak JJ, Obach RS, Ogilvie K, Patel NC, Pettersson M, Rai DK, Reese MR, Sammons MF, Sathish JG, Singh RSP, Steppan CM, Stewart AE, Tuttle JB, Updyke L, Verhoest PR, Wei L, Yang Q, Zhu Y. Owen DR, et al. Science. 2021 Dec 24;374(6575):1586-1593. doi: 10.1126/science.abl4784. Epub 2021 Nov 2. Science. 2021. PMID: 34726479 Free article.
DLL3: an emerging target in small cell lung cancer.
Owen DH, Giffin MJ, Bailis JM, Smit MD, Carbone DP, He K. Owen DH, et al. J Hematol Oncol. 2019 Jun 18;12(1):61. doi: 10.1186/s13045-019-0745-2. J Hematol Oncol. 2019. PMID: 31215500 Free PMC article. Review.
Diverse human astrocyte and microglial transcriptional responses to Alzheimer's pathology.
Smith AM, Davey K, Tsartsalis S, Khozoie C, Fancy N, Tang SS, Liaptsi E, Weinert M, McGarry A, Muirhead RCJ, Gentleman S, Owen DR, Matthews PM. Smith AM, et al. Among authors: owen dr. Acta Neuropathol. 2022 Jan;143(1):75-91. doi: 10.1007/s00401-021-02372-6. Epub 2021 Nov 12. Acta Neuropathol. 2022. PMID: 34767070 Free PMC article.
Multisystem Immune-Related Adverse Events Associated With Immune Checkpoint Inhibitors for Treatment of Non-Small Cell Lung Cancer.
Shankar B, Zhang J, Naqash AR, Forde PM, Feliciano JL, Marrone KA, Ettinger DS, Hann CL, Brahmer JR, Ricciuti B, Owen D, Toi Y, Walker P, Otterson GA, Patel SH, Sugawara S, Naidoo J. Shankar B, et al. Among authors: owen d. JAMA Oncol. 2020 Dec 1;6(12):1952-1956. doi: 10.1001/jamaoncol.2020.5012. JAMA Oncol. 2020. PMID: 33119034 Free PMC article.
Frontiers of therapy for hepatocellular carcinoma.
Heller M, Parikh ND, Fidelman N, Owen D. Heller M, et al. Among authors: owen d. Abdom Radiol (NY). 2021 Aug;46(8):3648-3659. doi: 10.1007/s00261-021-03065-0. Epub 2021 Apr 10. Abdom Radiol (NY). 2021. PMID: 33837453 Review.
Acute kidney injury in patients treated with immune checkpoint inhibitors.
Gupta S, Short SAP, Sise ME, Prosek JM, Madhavan SM, Soler MJ, Ostermann M, Herrmann SM, Abudayyeh A, Anand S, Glezerman I, Motwani SS, Murakami N, Wanchoo R, Ortiz-Melo DI, Rashidi A, Sprangers B, Aggarwal V, Malik AB, Loew S, Carlos CA, Chang WT, Beckerman P, Mithani Z, Shah CV, Renaghan AD, Seigneux S, Campedel L, Kitchlu A, Shin DS, Rangarajan S, Deshpande P, Coppock G, Eijgelsheim M, Seethapathy H, Lee MD, Strohbehn IA, Owen DH, Husain M, Garcia-Carro C, Bermejo S, Lumlertgul N, Seylanova N, Flanders L, Isik B, Mamlouk O, Lin JS, Garcia P, Kaghazchi A, Khanin Y, Kansal SK, Wauters E, Chandra S, Schmidt-Ott KM, Hsu RK, Tio MC, Sarvode Mothi S, Singh H, Schrag D, Jhaveri KD, Reynolds KL, Cortazar FB, Leaf DE; ICPi-AKI Consortium Investigators. Gupta S, et al. Among authors: owen dh. J Immunother Cancer. 2021 Oct;9(10):e003467. doi: 10.1136/jitc-2021-003467. J Immunother Cancer. 2021. PMID: 34625513 Free PMC article.
Regulatory T Cell Development in the Thymus.
Owen DL, Sjaastad LE, Farrar MA. Owen DL, et al. J Immunol. 2019 Oct 15;203(8):2031-2041. doi: 10.4049/jimmunol.1900662. J Immunol. 2019. PMID: 31591259 Free PMC article. Review.
Progress in the therapeutic inhibition of Cdc42 signalling.
Murphy NP, Mott HR, Owen D. Murphy NP, et al. Among authors: owen d. Biochem Soc Trans. 2021 Jun 30;49(3):1443-1456. doi: 10.1042/BST20210112. Biochem Soc Trans. 2021. PMID: 34100887 Free PMC article. Review.
Molecular subversion of Cdc42 signalling in cancer.
Murphy NP, Binti Ahmad Mokhtar AM, Mott HR, Owen D. Murphy NP, et al. Among authors: owen d. Biochem Soc Trans. 2021 Jun 30;49(3):1425-1442. doi: 10.1042/BST20200557. Biochem Soc Trans. 2021. PMID: 34196668 Free PMC article. Review.
Neoadjuvant atezolizumab for resectable non-small cell lung cancer: an open-label, single-arm phase II trial.
Chaft JE, Oezkan F, Kris MG, Bunn PA, Wistuba II, Kwiatkowski DJ, Owen DH, Tang Y, Johnson BE, Lee JM, Lozanski G, Pietrzak M, Seweryn M, Byun WY, Schulze K, Nicholas A, Johnson A, Grindheim J, Hilz S, Shames DS, Rivard C, Toloza E, Haura EB, McNamee CJ, Patterson GA, Waqar SN, Rusch VW, Carbone DP; LCMC study investigators. Chaft JE, et al. Among authors: owen dh. Nat Med. 2022 Oct;28(10):2155-2161. doi: 10.1038/s41591-022-01962-5. Epub 2022 Sep 12. Nat Med. 2022. PMID: 36097216 Free PMC article. Clinical Trial.
1,402 results